Sort
16,300 grants matching “fatty liver disease”
Novel strategies to resolve metabolic defects in the diabetic heart
$478,956Iain Scott · University Of Pittsburgh At Pittsburgh · R01 · FY2020 · HL
Novel strategies to resolve metabolic defects in the diabetic heart
$478,956Iain Scott · University Of Pittsburgh At Pittsburgh · R01 · FY2021 · HL
Targeting a Ceramide Double Bond to Treat Cardiometabolic Disorders
$478,921Scott A Summers · University Of Utah · R01 · FY2019 · DK
Phospholipid-Mediated Metabolic Control in Liver and Brown Adipose Tissue
$478,895David E Cohen · Brigham And Women'S Hospital · R01 · FY2014 · DK
Comprehensive Determination of Isoprostanoid Metabolism
$478,765Ginger Lohr Milne · Vanderbilt University Medical Center · R21 · FY2024 · AG
Effects of Macronutrients on Regulation of Endoplasmic Reticulum Stress in Human
$478,726Carol J Homko · Temple Univ Of The Commonwealth · R01 · FY2014 · DK
Optimized Metabolite Extraction, Separation, and Identification for Metabolomics
$478,616Andrew Patterson · Pennsylvania State University, The · R01 · FY2012 · ES
Transforming Growth Factor - Beta Superfamily Signaling in Diabetes and Obesity
$478,604Sushil Rane · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2011 · DK
Quantitative Oncologic PET-MR
$478,510Georges El Fakhri · Massachusetts General Hospital · R01 · FY2016 · CA
Quantitative Oncologic PET-MR
$478,510Georges El Fakhri · Massachusetts General Hospital · R01 · FY2015 · CA
Perfluoroalkyl substances and non-alcoholic fatty liver disease in children: Leveraging magnetic resonance imaging to unravel potential mechanisms and exposure mixture effects
$478,503Youssef Oulhote · Icahn School Of Medicine At Mount Sinai · R21 · FY2023 · ES
PPARgamma-regulated mechanisms in hepatocytes that promote NAFLD
$478,459Jose Cordoba-Chacon · University Of Illinois At Chicago · R01 · FY2022 · DK
Hepatic insulin resistance and metabolic disease
$478,392Morris F. White · Boston Children'S Hospital · R01 · FY2013 · DK
Lipid Function in Adiposity and Metabolism
$478,309Karen Reue · University Of California Los Angeles · P01 · FY2009 · HL
The Saint Louis University Component of the NASH CRN
$478,252Brent A Neuschwander-Tetri · Saint Louis University · U01 · FY2022 · DK
Role of SMPDL3B in obesity-associated non-alcoholic fatty liver disease
$478,167Shuxia Wang · University Of Kentucky · R01 · FY2025 · DK
Role of SMPDL3B in obesity-associated non-alcoholic fatty liver disease
$478,167Shuxia Wang · University Of Kentucky · R01 · FY2023 · DK
Dissecting the NRG4 hormonal checkpoint in metabolic liver disease
$478,123Jiandie D Lin · University Of Michigan At Ann Arbor · R01 · FY2023 · DK
Dissecting the NRG4 hormonal checkpoint in metabolic liver disease
$478,123Jiandie D Lin · University Of Michigan At Ann Arbor · R01 · FY2022 · DK
Biopsychosocial Determinants of Adolescent Obesity-Cardiovascular Risk
$477,701Sheila Gahagan · University Of California, San Diego · R01 · FY2017 · HL
Cellular and molecular mechanisms of target tissue resistance for mitigating GVHD severity
$477,565Pavan Reddy · University Of Michigan At Ann Arbor · R01 · FY2020 · CA
Cellular and molecular mechanisms of target tissue resistance for mitigating GVHD severity
$477,565Pavan Reddy · University Of Michigan At Ann Arbor · R01 · FY2016 · CA
Cellular and molecular mechanisms of target tissue resistance for mitigating GVHD severity
$477,565Pavan Reddy · University Of Michigan At Ann Arbor · R01 · FY2017 · CA
Transforming Growth Factor - Beta Superfamily Signaling in Diabetes and Obesity
$477,536Sushil Rane · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2017 · DK
Effect of sphingomyelin biosynthesis on atherosclerosis
$477,521Xian-Cheng Jiang · Suny Downstate Medical Center · R01 · FY2022 · HL